actinium has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chea, J; Colcher, D; Li, L; Liu, A; Miller, AD; Minnix, M; Poku, E; Rockne, RC; Shively, JE; Wong, JYC; Yazaki, PJ | 1 |
| Borchardt, PE; McDevitt, MR; Miederer, M; Scheinberg, DA; Yuan, RR | 1 |
| Bruland, ØS; Henriksen, G; Larsen, RH; Michaelsen, TE; Schoultz, BW | 1 |
3 other study(ies) available for actinium and Cancer of Ovary
| Article | Year |
|---|---|
TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Molecular Targeted Therapy; Ovarian Neoplasms; Radioimmunotherapy; Tissue Distribution | 2021 |
Targeted actinium-225 in vivo generators for therapy of ovarian cancer.
Topics: Actinium; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dimerization; Female; Humans; Indium Radioisotopes; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Radioimmunotherapy; Tissue Distribution; Transplantation, Heterologous; Trastuzumab; Tumor Cells, Cultured | 2003 |
Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides.
Topics: Actinium; Alpha Particles; Carrier Proteins; Cell Line, Tumor; Coated Materials, Biocompatible; Drug Carriers; Drug Stability; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Immunoglobulin Fab Fragments; Liposomes; Metabolic Clearance Rate; Ovarian Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Radium; Receptors, Cell Surface; Stereoisomerism | 2004 |